1. MAPK/ERK Pathway GPCR/G Protein Apoptosis
  2. SOS1 Ras Apoptosis
  3. SOS1/KRAS-IN-2

SOS1/KRAS-IN-2 (Compound 20) is a SOS1::KRASG12C protein-protein interaction inhibitor with a IC50 of 4.11 nM. SOS1/KRAS-IN-2 blocks the interaction between SOS1 and KRASG12C. SOS1/KRAS-IN-2 induces cell Apoptosis. SOS1/KRAS-IN-2 exhibits anticancer activity against colorectal cancer and tongue squamous cell carcinoma.

For research use only. We do not sell to patients.

SOS1/KRAS-IN-2

SOS1/KRAS-IN-2 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All Ras Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

SOS1/KRAS-IN-2 (Compound 20) is a SOS1::KRASG12C protein-protein interaction inhibitor with a IC50 of 4.11 nM. SOS1/KRAS-IN-2 blocks the interaction between SOS1 and KRASG12C. SOS1/KRAS-IN-2 induces cell Apoptosis. SOS1/KRAS-IN-2 exhibits anticancer activity against colorectal cancer and tongue squamous cell carcinoma[1].

IC50 & Target[1]

KRAS G12C-SOS1

4.11 nM (IC50)

In Vitro

SOS1/KRAS-IN-2 potently inhibits the SOS1::KRASG12C protein-protein interaction with an IC50 of 4.11 ± 0.19 nM[1].
SOS1/KRAS-IN-2 (7 days) inhibits DLD-1 colorectal cancer cell proliferation with an IC50 of 134.4 ± 5.12 nM[1].
SOS1/KRAS-IN-2 (100 μM) inhibits CAL-27 human tongue squamous carcinoma cell proliferation by 84.41 ± 10.36%[1].
SOS1/KRAS-IN-2 (100-400 nM; 24 h) induces dose-dependent apoptosis in DLD-1 colorectal cancer cells[1].
SOS1/KRAS-IN-2 (100-400 nM; 24 h) induces dose-dependent G0/G1 cell cycle arrest in DLD-1 colorectal cancer cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis[1]

Cell Line: DLD-1 colorectal cancer cells
Concentration: 100-400 nM
Incubation Time: 24 h
Result: Induced apoptosis in a dose-dependent manner, with the percentage of apoptotic cells increasing progressively at higher concentrations.
Detected apoptosis starting at 100 nM.
Molecular Weight

441.45

Formula

C23H22F3N5O

SMILES

CC1=NC(N[C@@H](C2=CC=CC(C(F)F)=C2F)C)=C3C=C(N(C4COCC4)C=N5)C5=CC3=N1

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
SOS1/KRAS-IN-2
Cat. No.:
HY-181807
Quantity:
MCE Japan Authorized Agent: